[Pharmacological action of 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrolinone hydrochloride (doxapram). 1. The action on the central nervous system].
D000577:Amides / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D004285:Dogs; D004315:Doxapram / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D004562:Electrocardiography; D005029:Ethylenediamines / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D008297:Male; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012119:Respiration / Q000187:drug effects; D012640:Seizures / Q000139:chemically induced; D013564:Sympathetic Nervous System / Q000187:drug effects; D014628:Vagotomy
D000577:Amides; D000697:Central Nervous System Stimulants; D005029:Ethylenediamines; D006584:Hexamethonium Compounds; D009025:Morpholines; D001285:Atropine; D012110:Reserpine; D004315:Doxapram; D010424:Pentobarbital; D010646:Phentolamine